A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)
Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and Mylan Inc.
Par Pharmaceutical Companies Inc. (PRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% | |
| 2. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 3. | Havens Advisors Nancy Havens-Hasty | 0 | $0 | 0% | |
| 4. | Visium Asset Management Jacob Gottlieb | 0 | $0 | 0% | |
| 5. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.50 | 2,000 | Officer | 49,320 | 2011-09-06 | Filing | |
| $25.92 | 8,000 | Officer, Director | 23,000 | 2011-09-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.05 | 1,300 | Director | 3,500 | 2012-03-19 | Filing | |
| $37.05 | 700 | Director | 4,800 | 2012-03-19 | Filing | |
| $37.03 | 100 | Director | 5,500 | 2012-03-19 | Filing | |
| $37.03 | 500 | Director | 5,600 | 2012-03-19 | Filing | |
| $37.02 | 600 | Director | 6,100 | 2012-03-19 | Filing |
Institutional Investors' Holdings
News See All
Billionaire Hedge Funds
